12/16
02:21 pm
imnm
Rating for IMNM
Low
Report
Rating for IMNM
12/16
02:21 pm
imnm
Rating for IMNM
Low
Report
Rating for IMNM
12/16
10:09 am
imnm
Immunome (NASDAQ:IMNM) had its "buy" rating reaffirmed by analysts at Lake Street Capital.
Low
Report
Immunome (NASDAQ:IMNM) had its "buy" rating reaffirmed by analysts at Lake Street Capital.
12/16
09:26 am
imnm
Rating for IMNM
Medium
Report
Rating for IMNM
12/16
08:47 am
imnm
Rating for IMNM
Low
Report
Rating for IMNM
12/16
08:47 am
imnm
Rating for IMNM
Low
Report
Rating for IMNM
12/16
08:43 am
imnm
Immunome (NASDAQ:IMNM) had its "buy" rating reaffirmed by analysts at Guggenheim.
Low
Report
Immunome (NASDAQ:IMNM) had its "buy" rating reaffirmed by analysts at Guggenheim.
12/16
08:43 am
imnm
Immunome (NASDAQ:IMNM) had its "buy" rating reaffirmed by analysts at Guggenheim.
Low
Report
Immunome (NASDAQ:IMNM) had its "buy" rating reaffirmed by analysts at Guggenheim.
11/17
07:57 am
imnm
Rating for IMNM
Medium
Report
Rating for IMNM
11/7
11:30 pm
imnm
Immunome (NASDAQ:IMNM) had its "outperform" rating reaffirmed by analysts at Wedbush. They now have a $21.00 price target on the stock.
Medium
Report
Immunome (NASDAQ:IMNM) had its "outperform" rating reaffirmed by analysts at Wedbush. They now have a $21.00 price target on the stock.
11/7
11:30 pm
imnm
Immunome (NASDAQ:IMNM) had its "outperform" rating reaffirmed by analysts at Wedbush. They now have a $21.00 price target on the stock.
Medium
Report
Immunome (NASDAQ:IMNM) had its "outperform" rating reaffirmed by analysts at Wedbush. They now have a $21.00 price target on the stock.
9/22
07:55 am
imnm
Rating for IMNM
Low
Report
Rating for IMNM
9/22
07:55 am
imnm
Rating for IMNM
Low
Report
Rating for IMNM
9/22
07:55 am
imnm
Rating for IMNM
Low
Report
Rating for IMNM
9/22
06:15 am
imnm
Immunome initiated with a Buy at Goldman Sachs
Low
Report
Immunome initiated with a Buy at Goldman Sachs
9/22
06:15 am
imnm
Immunome initiated with a Buy at Goldman Sachs
Low
Report
Immunome initiated with a Buy at Goldman Sachs
9/22
06:15 am
imnm
Immunome initiated with a Buy at Goldman Sachs
Low
Report
Immunome initiated with a Buy at Goldman Sachs